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Abstract: A simple chromatographic procedure is reported for the determination of 
some less prescribed but equally important benzodiazepines (Clotiazepam, clozapine 
and pinazepam) in serum. The optimization studies have been made in CN, C18 and 
C8 columns, using mobile phase containing sodium dodecyl sulphate (SDS) modified 
with either propanol, butanol or pentanol. The method proposed for the determination 
of the three benzodiazepines using a mobile phase of 0.13 M SDS, 2.4% pentanol-
0.01 M phosphate buffer- 0.1% triethylamine (pH 7) at 25 ºC and UV detection 
(240 nm) in a C8 column. The serum samples was injected directly, without any 
pretreatment, eluted in less than 8 min, in accordance to their relative polarities, as 
indicated by their octanol-water partition coefficients. The limits of detection (ng/mL) 
was in the 1.6 to 5.6 and 7 to 87 range, for aqueous and serum samples, respectively. 
Repeatability and intermediate precision was tested for three different concentrations 
of the drugs, resulting in the 0.1 to 2 range. The results obtained here for the 
separation of the three benzodiazepines in serum were also counter checked at 
Department of Bio-analytical Chemistry, Universitat Jaume I, Castelló, Spain. 
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Introduction 
The introduction of chromatographic techniques in analytical toxicology in the late 1950s 
represented the first key moment in the evolution of systematic toxicological analysis 
(STA). Since that time it became possible to detect the presence of drugs in biological  
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samples from its behavior in a given chromatographic system, provided that the same drug 
had been previously analyzed in that system and its retention behavior has been recorded1. 
One of the most important groups of drugs for monitoring is benzodiazepines. The 
Benzodiazepines cause sedation, hypnosis, decreased anxiety, muscle relaxation and some 
of them also possess anticonvulsant activity. In short these are the most important class of 
drugs used widely for the treatment of anxiety related condition. These drugs affect activity 
at all level of the neuraxis, though some structures are affected more than the others. All 
benzodiazepines are qualitatively similar in their effects on the important sleep parameters2. 
Administration of benzodiazepines to the mother before delivery causes apnoeic spells, 
hypotonia and hypothermia (floppy baby syndrome). They are often abused by the young 
illicit drug user and may lead to profound behavioral effects3,4. Benzodiazepines are known 
to cause dependence and addiction with tolerance and withdrawal effects in some patients. 
The older population is also more likely to develop significant adverse CNS effects from the 
use of benzodiazepines and it also present with an increased risk of motor vehicle crash. 
Because of a significant risk of agranulocytosis (in which the white blood cell count drops 
and increases the risk of infection), a potentially life-threatening adverse event, clozapine 
should be reserved for use in the treatment of severely ill schizophrenic patients who fail to 
show an acceptable response to adequate courses of standard antipsychotic drug treatment. 
Patients being treated with clozapine must have a baseline white blood cell (WBC) and 
differential count before initiation of treatment as well as regular WBC counts during 
treatment and for four weeks after discontinuation of treatment. 
 Because of their wide abuse, benzodiazepines are included in most drug abuse-
screening program. The determination of these less preferred benzodiazepines i.e. 
clotiazepam, clozapine and pinazepam is important as they have important biological 
properties which depend on their accurate concentration in blood. While benzodiazepines 
can be measured using a variety of techniques their structural diversity and wide variations 
in potency provide a challenge for laboratories to detect all relevant numbers in one 
analytical scheme.  
 Reviews of the analysis of benzodiazepines have been published5-8. Several other 
analytical methods are described in the literature for the screening and quantitation of 
benzodiazepines.  From the first approaches with paper and thin-layer chromatography9,10 we 
have witnessed within a few years a rapid development of different chromatographic 
techniques, such as gas chromatography with the introduction of capillary columns (GC)11,12  
and high performance liquid chromatography (HPLC)13,14 particularly with the introduction of 
the reversed phase mode, that have found widespread application in benzodiazepines. 
Presently GC coupled to a mass spectrometer (MS) is considered as the method of choice for a 
confirmation15,16. Indeed this is a highly sensitive and specific method, which identifies drug 
without ambiguity, but the equipment and maintenance are relatively costly and need qualified 
operators. Other chromatographic methods have been developed for the identification of 
benzodiazepines in biological samples: GC coupled with electron capture, flame ionization 
detector and reversed phase liquid chromatography coupled with UV detector17,18.  
 Analysis of serum samples for drugs presents special problems because of the high and 
variable protein content. If proteins are not completely removed from blood serum, they may 
result in a poor resolution of otherwise easily determined sample constituents. The protein 
retained on the column leads to high backpressure and finally blocking the column, which 
completely destroys the separation. In view of this, it is advisable to design an extraction 
procedure for biological matrix that does not allow small amount of  disturbing components, 
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such as proteins, to be left in the sample matrix. Although sample pretreatment or protein 
precipitation can eliminate matrix effects, it is not suitable for routine analysis in the clinical 
laboratories because it adds to the total analysis time, the risk of contamination and the risk 
of sample loss. 
 Owing to the capability of SDS to solubilize proteins, serum samples can directly be 
injected into the column using micellar liquid chromatography (MLC).  MLC is a variant of 
RP-HPLC in which the mobile phase is composed of a surfactant in a concentration above 
the critical micellar concentration. In some cases a modifier, such as 1-propanol, 1-butanol, 
1-pentanol, is added to decrease the retention factor and increase the efficiencies. The direct 
injection of serum samples in MLC allows rapid analysis, which can be performed on very 
small sample volumes. Our goal was to achieve separation conditions that could permit 
complete resolution of benzodiazepines from endogenous components of serum matrix. 
These conditions permitted direct injection of plasma samples without the need for sample 
pretreatment prior to MLC analysis. 
Experimental  
The reagents used in the mobile phases were: the surfactant sodium dodecyl sulphate (99% 
purity, Merck, India), the modifiers 1-propanol, 1-butanol, 1-pentanol (BDH, India) and the 
buffer compounds sodium dihydrogenphosphate and HCl or NaOH (Ranchem, India). 
Triethylamine and isopropylamine was purchased from Merck, India. The mobile phases 
were filtered through 0.45 µm Nylon membranes (Micron Separations, Westboro, MA, 
USA). Methanol (BDH, India) was used to condition the column. 
 The analytes were: pinazepam (Tedec-Meiji Farma, Madrid), clotiazepam and clozapin  
were from novartis Pharmaceuticals (Barcelona, Spain). The above drugs were kindly 
donated by the cited pharmaceutical companies in Spain. Stock solutions containing 
100 µg/mL were prepared by dissolving the compounds in a few milliliters of methanol, 
with the aid of an ultrasonic bath. The water used was double distilled water. The serums in 
blank and with the drug used for the analysis were kindly donated by the local pathology, 
Sagar, India and were stored below 0 ºC in refrigerator. 
Apparatus 
The pH of the mobile phases was measured with a systonic, India, pH meter, provided with 
a combined Ag/AgCl/glass electrode. UV spectra and absorbance measurements were 
obtained with a Shimadzu UV-Vis spectrophotometer, Shimazdu, Japan. Maximum 
wavelengths and molar absorptivities of the drugs were recorded using the above 
spectrophotometer. 
 A Beckman chromatograph was used for the separation, which was provided with an isocratic 
pump, manual injector, a UV-visible detector set at 240 nm. The signal was acquired by a PC 
computer connected to the chromatograph. Measurement of peak properties and optimization of 
mobile phase composition were assisted by the MICHROM software. The columns used for the 
analysis were, C-18, CN and Kromasil C-8 (Scharlau, Spain, 5 µm particle size,               
250 mm × 4.6 mm i.d.). The flow-rate used was 1 mL/min and the injection volume was 20 µL. 
Chromatographic analysis 
The composition of the micellar mobile phase recommended for the determination of the 
drugs studied in this work is: 0.13 M SDS, 2.4% pentanol, 0.01 M sodium 
dihydrogenphosphate and 0.1% triethylamine. The pH was adjusted at 7 with HCl/NaOH 
before the addition of the modifiers. 
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 The serum sample used was spiked with the benzodiazepines. The sample solutions 
should be filtered before injection into the chromatograph. The standard solutions of the 
drugs were also filtered. Filtration was always performed into the vials through 0.45 µm 
Nylon membranes of 13 mm diameter. 
Results and Discussion 
Nature of the modifier 
The polarities of benzodiazepines are low. Consequently, their retention on a C8 column was 
excessive when eluted with pure micellar mobile phases of SDS, and after the addition of the 
modifiers methanol or propanol, even at high concentrations. Elution at appropriate retention 
times was finally achieved by the addition of an alcohol with a longer chain, such as butanol 
or pentanol. There are references in the MLC literature on the use of pentanol as a modifier 
in analytical procedures. This alcohol permitted the elution of diverse hydrophobic 
compounds, such as steroids (0.1 M SDS-7% pentanol mobile phase)20  and sulphonamides 
(0.05 M SDS-2.4% pentanol mobile phase)21. Butanol has not been employed before in 
MLC analytical applications, but it has been compared with other modifiers in 
physicochemical studies22,23. 
 Figure 1 shows a contour map of the mobile phase containing SDS as surfactant and 
pentanol as modifier. The figure shows that at the lowest concentration of SDS and pentanol 
there is no resolution as is evident form the contour at 0.05 M SDS and 2% pentanol. As we 
increase the concentration of pentanol and keep the SDS concentration fixed at 0.05 M, 
efficiency increases but the resolution is not satisfactory. Therefore as observed in figure 1 
the best resolution can be achieved somewhere in the range of 0.11-0.14 M SDS and 2-3% 
of pentanol. 
 
Figure 1. Contour map of resolution for three benzodiazepines eluted with SDS-pentanol 
mobile phase 
 Pentanol yielded better efficiencies and lesser retentions than butanol. The peaks of all 
the three benzodiazepines could also be resolved with butanol but with more analysis time. 
pentanol was thus preferred to optimize the separation of the three drugs. 
pH selection 
No reference was found in the literature on the protonation constants of the studied drugs, 
but for other benzodiazepines at least two acid-base equilibria with log K1 8-11 and  log K2 2-3  
Time, min 
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have been reported2. Log K2 is expected to increase in the presence of the anionic SDS 
micelles, owing to stabilization of the positive charge of the protonated drugs. Thus, at pH 3, 
benzodiazepines should be partially protonated at the N-4 position. 
 A series of measurements were carried out with 0.13 M SDS-2.4% (v/v) pentanol 
mobile phases, where the pH was varied between 3 and 7. The retention was 
effectively somewhat larger below pH 4 for clozapine and pinazepam. Owing to the 
greater over-lapping of these two compounds at pH 4-5, mobile phases were next 
buffered at pH 7. 
Concentrations of surfactant, alcohol and amine 
The elution behavior of the benzodiazepines was usual in MLC: an increase in the 
concentration of surfactant resulted in decreased retentions and efficiencies and an increase 
in the concentration of alcohol modifier yielded decreased retentions but enhanced 
efficiencies. Due to the low polarity of the drugs, the efficiencies were however still low 
with added alcohols. The elution strength for pentanol was greater than for SDS, in the 1-6% 
pentanol and 0.05-0.15 M SDS concentration ranges. 
 Amines, such as triethylamine (TEA)24 and isopropylamine25, have been added to the 
mobile phase in some analytical RPLC procedures proposed for benzodiazepines. The use of 
an amine is a common practice to protect the silanol groups of the stationary phase, in order 
to increase peak efficiencies for compounds having amine groups. The effect of TEA on the 
separation of the drugs was thus examined. The concentration of TEA was varied in the         
0-0.2% concentration range for a 0.13 M SDS-2.4% pentanol mobile phase buffered at pH 7. 
The addition of TEA enhanced the efficiencies for these compound. However, the amine 
behaved as another modifier and the retention factors of the compounds were reduced. For 
this reason, the concentration of TEA was limited to 0.1%.  
 Using the resolution diagram for SDS-pentanol mobile phases, resulting that 0.13 M 
SDS-2.4% (v/v) pentanol, 0.1% TEA and pH 7 is the most adequate for giving good 
resolution, low analysis time and highest efficiencies. In this mobile phase the elution order 
was (min): pinazepam (5.0), clotiazepam (6.2), clozapine (7.3). For individual determination 
of the three benzodiazepines, Figure 2 shows the mobile phases that give analysis time 
of 8 min using pentanol. 
0 2 4 6 8 10
Time (min)  
 
Figure 2. Chromatogram of pinazipam, clotiazepam and clozapine eluted with 0.13 M SDS-
2.4% pentanol.   
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Linearity and detection limit 
Calibration curves were constructed for each benzodiazepine, using the measured areas of 
the chromatographic peaks at six increasing concentrations in the range from 1 to 50: g mL-1 
in spiked serum samples. The slopes, intercepts and regression coefficients of the calibration 
curves were in satisfactory range (Table 1).  
Table 1. Calibration parameters and limits of detection (LODs in ng mL-1, 3s criterium) for 
the determination of three benzodiazepines using the optimum mobile phase SDS130 mM -
2.4% (v/v) pentanol-pH 7 and ultraviolet detection at 240 nm 
Sample Slope Intercept r LOD 
Pinazepam 86.17 +0.560 0.9999 0.3 
Clotiazepam 72.07 +1.887 0.9999 0.3 
Clozapine 59.18 -0.228 0.9999 0.4 
 Limits of detection (LODs, 3s criterion) were evaluated by the injection of series of 10 
solutions, containing the benzodiazepines at the lowest concentration of the calibration 
curve. The LODs were between 1.6 to 5.6 ng/mL and 7 to 87 ng/mL range, for aqueous and 
serum samples, respectively. The values of the LODs were similar to those usually reported 
in the literature and permitted the detection and quantification of the benzodiazepines in 
serum with the method proposed in this work, taking into account that the serum samples 
can be injected without any previous treatment. 
Repeatability and intermediate precision 
Repeatability values were calculated by measuring the areas of the peaks obtained by 
injection of series of ten spiked serum samples with three different concentrations of 
benzodiazepines (Table 2). The injections were performed in the calibration range indicated 
above. The variation coefficient was always below 1.8%. The intermediate precision was 
also obtained and the variation coefficients of the peak areas in samples injected during five 
different days were in the 0.1-2% range. 
Analyses of benzodiazepines in spiked serum samples 
The background signal of serum, due to proteins (wide band in the head of the 
chromatograms) and several endogenous compounds (peaks at diverse retention times) can 
seriously affect the detection of the benzodiazepines. Direct injection of spiked serum 
samples (without any dilution) mainly made the detection difficult for the substances that are 
less retained. However, dilution of the spiked serum samples before its injection reduced the 
width of the protein band and of some endogenous peaks, allowing the detection of the 
drugs. 
Table 2. Intra and interday precision (RSD in %, n = 10) using three different 
concentrations, of three benzodiazepines  (c1 = 600, c2 = 300 and c3 = 150 ng  mL-1) using 
the optimum mobile phase SDS130 mM -2.4% (v/v) pentanol-pH 7 and ultraviolet detection 
at 240 nm 
Intra-day Inter-day Sample 
c1 c2 c3 c1 c2 c3 
Pinazepam 0.22 0.66 0.80 0.20 0.43 0.56 
Clotiazepam 0.34 0.89 1.11 0.46 0.8 0.95 
Clozapine 0.24 0.58 0.97 0.54 1.07 1.60 
Time, min 
Time, min 
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 Moreover, the injection of a large number of serum samples can produce damage to the 
packing material, thus shortening the life of the column, or can force a frequent regeneration 
of the stationary phase. It was therefore decided to carry out the analysis of serum samples 
after their dilution. In these conditions, retention times were unchanged at least after 250 
injections into the chromatographic system. For all the benzodiazepines studied, the 
sensitivity achieved after dilution in a 1:10 factor was adequate for their detection in serum. 
 Figure 3(A) shows the chromatograms in the MLC optimum mobile phase of blank 
serum sample while Figure 3(B) is the chromatogram of spiked serum samples containing 
the individual benzodiazepines. The results indicate that the MLC procedure can be easily 
used for the determination of three benzodiazepines (pinazepam, clozapine and clotiazepam) 
in serum samples with analysis time below 8 min using a mobile phase of 0.13 M SDS-2.4% 
pentanol, 0.1% TEA at pH 7. The procedure is sensitive enough to monitor these drugs in 
serum at the therapeutic and toxicological levels, taking into account that the serum sample 
was injected without any previous treatment. 
0 2 4 6
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Figure 3. (A) Chromatogram of blank serum sample eluted in optimum mobile phase (B) 
Chromatogram of spiked serum sample containing three benzodiazepines in optimum 
mobile phase 
A 
B 
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